Industry News
Life Technologies acquires Compendia Bioscience
Life Technologies has announced the acquisition of Compendia Bioscience, a pre-eminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development. [ + ]
QRxPharma scores Canadian licensing deal for MoxDuo
QRxPharma (ASX:QRX) has secured a potentially lucrative licensing deal covering the Canadian market for its pain relief drug, MoxDuo IR, which is currently awaiting marketing approval in Canada and the US. [ + ]
Merck partnership accelerates needle-free vaccine delivery
A University of Queensland (UQ) invention that will deliver vaccines without the need for needles has struck a significant partnership with US-based pharmaceutical giant Merck. [ + ]
AusBiotech welcomes McKeon Review focus on translation
The McKean Review has reported recently, providing a consultation paper for comment until the end of October. [ + ]
Stem cell pioneers receive Nobel Prize
Two pioneers of stem cell science have received the Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed to become pluripotent". [ + ]
Vaxxas partners with Merck on Nanopatch needle-free vaccine patch
Start-up Vaxxas has picked up its first major pre-licensing and evaluation deal for Nanopatch, the needle-free vaccine technology developed at the AIBN, collaborating with Merck. [ + ]
Better seeds and plant species for NZ farmers
A New Zealand research program being co-funded by the government aims to deliver better seeds and plant species for farmers, in order to help improve animal productivity and minimise environmental impacts. [ + ]
Partnership boosts research on new-generation biofuels
RMIT University has signed a multimillion-dollar partnership with World Wide Carbon Credits Australia to develop an algae-based biofuel at a commercial scale. [ + ]
AtCor wins $3.2m SphygmoCor deal
AtCor Medical (ASX:ACG) has won a $3.2 million contract to supply its SphygmoCor specialist blood pressure monitoring systems for multiple clinical trial sites. [ + ]
Co-opting a killer virus peptide to combat cancer
A team at RMIT has used an advanced new technique to synthesise a key peptide from the myxoma virus that is responsible for its cancer killing clout, and have found this peptide can do its dirty work without harming healthy cells [ + ]
Search for element 113 concluded at last
The most unambiguous data to date on the elusive 113th atomic element has been obtained by researchers at the RIKEN Nishina Center for Accelerator-Based Science (RNC). [ + ]
Exciting new science for Australian primary schools
The Australian Academy of Science’s science education program for primary schools, PrimaryConnections, released 10 new units last week, fully aligned to the national science curriculum. [ + ]
Unique mechanism identified in bacteria as potential target for developing new antibiotics
Researchers from Florida Atlantic University’s Charles E. Schmidt College of Medicine have identified a unique mechanism in bacteria that has the potential to serve as a target for developing new antibiotics for diseases such as AIDS and soft tissue infections including respiratory and urogenital tracts. [ + ]
Quansys Biosciences appoints Sapphire Bioscience as distributor in Australia and NZ
On 21 August 2012, Quansys Biosciences announced that its products are now distributed in Australia and New Zealand by Sapphire Bioscience. [ + ]
Bluechiip cashes in on R&D Tax Incentive
Bluechiip (ASX:BCT) has become the latest life science company to take advantage of the government's R&D Tax Incentive. [ + ]
